ST-Martinus SRL
ST-Martinus reported total assets of 301,576 € at the end of the 2025 financial year (annual accounts filed with the NBB on 25 Jun 2026).
The score of ST-Martinus shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +6 % Total assets +4 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
ST-Martinus's annual accounts
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Net result | 4,700 € | ||||
| Equity | 289,301 € | ||||
| Cash | 256,243 € | ||||
| EBITDA | 17,052 € | ||||
| Total assets | 301,576 € |
Filed annual accounts
- Year ended 31 Dec 2025filed on 25 Jun 2026
- Year ended 31 Dec 2024filed on 26 Jun 2025
- Year ended 31 Dec 2023filed on 28 Jun 2024
- Year ended 31 Dec 2022filed on 01 Jun 2023
- Year ended 31 Dec 2021filed on 02 Jun 2022
ST-Martinus's financial analysis
- Solvency95.9%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of ST-Martinus
ST-Martinus's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0862.802.231
- VAT number
- BE0862802231
- Peppol
- Registered · 0208:0862802231 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 20 Jan 2004
- Registered office
- 2400 Mol
- Latest accounts
- 2025 · filed on 25 Jun 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
ST-Martinus (SRL) has been based in Mol since 2004, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 4,700 € and equity of 289,301 €; its revenue is not published. Its solvency stands at 95.9%, above the median of its sector (44.2%).
Companies similar to ST-Martinus
Companies in the same business, of comparable size and area, outside its group.
- CVHD Retail sale of pharmaceutical products Bilzen-Hoeselt · balance sheet 301,231 €
- Pharmacie Failly Retail sale of pharmaceutical products La Louvière · balance sheet 300,445 €
- Delpharma Retail sale of pharmaceutical products Charleroi · balance sheet 302,800 €
- Warquigniespharma Retail sale of pharmaceutical products Colfontaine · balance sheet 299,659 €
- Pharmanderlecht Retail sale of pharmaceutical products Anderlecht · balance sheet 304,329 €
- Magistra - Pharma Retail sale of pharmaceutical products Schaerbeek · balance sheet 304,456 €
- Leveugle Retail sale of pharmaceutical products Deinze · balance sheet 297,608 €
- Sanaspe Retail sale of pharmaceutical products Anderlecht · balance sheet 305,664 €
Frequently asked questions about ST-Martinus
What is the revenue of ST-Martinus?
ST-Martinus files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of ST-Martinus?
In Belgium, the VAT number is the company number prefixed with BE: BE0862802231 for ST-Martinus, if the company is VAT-registered. Its company number (CBE) is 0862.802.231.
Where is the registered office of ST-Martinus?
According to the CBE register, the registered office of ST-Martinus is in 2400 Mol.
What is the equity of ST-Martinus?
At the close of the 2025 financial year, the equity of ST-Martinus amounts to 289,301 €, a solvency of 95.9% of total assets.
Who manages ST-Martinus?
The register lists 2 active mandates at ST-Martinus. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of ST-Martinus
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →